Report cover image

Australia and New Zealand PCR Systems Market Report and Forecast 2024-2032

Publisher Expert Market Research
Published Feb 13, 2024
Length 120 Pages
SKU # EMAR18558314

Description

Australia and New Zealand PCR Systems Market Report and Forecast 2024-2032


Australia and New Zealand PCR Systems Market Report and Forecast 2024-2032

Australia and New Zealand PCR Systems Market Outlook

The Australia and New Zealand PCR systems market size is anticipated to be driven by the increasing demand from Asia Pacific PCR systems market, which is likely to grow at a CAGR of 8.4% during the forecast period of 2024-2032. The market growth can be attributed to the rising emphasis on preventing pathogen associated infections and technical advancements in the medical research domain.

PCR Systems: Introduction

PCR systems are sophisticated laboratory equipment used to amplify tiny segments of DNA or RNA. By replicating a specific DNA sequence millions of times, these systems enable detailed analysis and study of genetic material. Essential in fields like molecular biology and medical diagnostics, PCR systems are pivotal for applications such as pathogen detection, genetic sequencing, and forensic analysis, playing a crucial role in disease diagnosis, research, and crime scene investigation.

Key Trends in the Australia and New Zealand PCR Systems Market

Continuous innovation, such as real-time PCR and digital PCR, offers higher accuracy, sensitivity, and throughput, meeting diverse research and diagnostic needs.

A shift towards miniaturized, portable PCR systems enabling rapid, on-site diagnostic testing, particularly useful in remote or resource-limited settings.

Increasing demand for customizable and automated PCR solutions to streamline workflows, reduce human error, and increase productivity in laboratories.

Development of systems capable of multiplexing to allow simultaneous detection of multiple targets in a single test, optimizing efficiency and cost-effectiveness.

Strong focus on complying with regulatory standards to ensure accuracy, reliability, and safety in diagnostic testing and research.

Incorporation of advanced data analysis and artificial intelligence to manage the large volumes of data generated, enhancing result interpretation and decision-making.

Australia and New Zealand PCR Systems Market Segmentation

Market breakup by Product
  • Reagents and Consumables
  • Instruments
  • Software and Services
Market breakup by Technique
  • Conventional PCR
  • Real-time PCR
  • Digital PCR
  • Reverse Transcription PCR
  • Hot-start PCR
  • Multiplex PCR
  • Other PCR Techniques
Market breakup by Application
  • Gene Expression Analysis
  • Genetic Sequencing
  • Genotyping
  • Nucleic Acid Detection
  • Nucleic Acid Synthesis
  • Standard Validation/Verification
  • Diagnostic Applications
  • Environmental Applications
  • Others
Market breakup by End User
  • Hospitals and Diagnostic Centres
  • Healthcare Industries
  • Academia and Government Organisations
  • Pharma-biotech Companies
  • Applied Industries
  • Other End Users
Market Breakup by Country
  • Australia
  • New Zealand
Australia and New Zealand PCR Systems Market Overview

In Australia, the PCR systems market is characterized by advanced healthcare research and a robust biotechnology sector. Significant investment in R&D activities, especially in healthcare and agricultural biotechnology, driving the demand for PCR systems. High focus on infectious disease control and genetic disorder management, leading to increased use of PCR in diagnostics and personalized medicine. Strong network of universities and research institutions adopting PCR systems for various scientific studies. Emphasis on high-quality standards and regulatory compliance in the biotechnology and healthcare sectors, influencing PCR system quality and usage.

In New Zealand, the PCR systems market is shaped by a commitment to high-quality healthcare and agricultural excellence. Usage of PCR systems in monitoring and controlling zoonotic and infectious diseases, crucial for both human healthcare and the significant agricultural sector. Investment in biotechnological research, with PCR systems playing a central role in genetic, medical, and agricultural research. Continuous development of healthcare infrastructure, promoting the adoption of advanced diagnostic methods, including PCR technologies. High standards for diagnostic and research tools, ensuring PCR systems meet the required precision and reliability for critical applications.

Australia and New Zealand PCR Systems Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • bioMérieux SA
  • PerkinElmer, Inc.
  • Fluidigm Corporation
  • Eppendorf AG
  • Promega Corporation
  • Analytik Jena AG (Endress+Hauser Group)
  • Illumina, Inc.
  • Becton, Dickinson and Company (BD)
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.

Table of Contents

120 Pages
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Australia and New Zealand PCR Systems Market Overview
3.1 Australia and New Zealand PCR Systems Market Historical Value (2017-2023)
3.2 Australia and New Zealand PCR Systems Market Forecast Value (2024-2032)
4 Australia and New Zealand PCR Systems Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Australia and New Zealand PCR Systems Market Segmentation
5.1 Australia and New Zealand PCR Systems Market by Product
5.1.1 Market Overview
5.1.2 Reagents and Consumables
5.1.3 Instruments
5.1.4 Software and Services
5.2 Australia and New Zealand PCR Systems Market by Technique
5.2.1 Market Overview
5.2.2 Conventional PCR
5.2.3 Real-time PCR
5.2.4 Digital PCR
5.2.5 Reverse Transcription PCR
5.2.6 Hot-start PCR
5.2.7 Multiplex PCR
5.2.8 Other PCR Techniques
5.3 Australia and New Zealand PCR Systems Market by Application
5.3.1 Market Overview
5.3.2 Gene Expression Analysis
5.3.3 Genetic Sequencing
5.3.4 Genotyping
5.3.5 Nucleic Acid Detection
5.3.6 Nucleic Acid Synthesis
5.3.7 Standard Validation/Verification
5.3.8 Diagnostic Applications
5.3.9 Environmental Applications
5.3.10 Others
5.4 Australia and New Zealand PCR Systems Market by End User
5.4.1 Market Overview
5.4.2 Hospitals and Diagnostic Centres
5.4.3 Healthcare Industries
5.4.4 Academia and Government Organisations
5.4.5 Pharma-biotech Companies
5.4.6 Applied Industries
5.4.7 Other End Users
5.5 Australia and New Zealand PCR Systems Market by Country
5.5.1 Market Overview
5.5.2 Australia
5.5.3 New Zealand
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication Year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by Year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
10.1 Regulatory Overview
11 Supplier Landscape
11.1 Thermo Fisher Scientific Inc.
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Roche Diagnostics (a division of F. Hoffmann-La Roche Ltd)
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Bio-Rad Laboratories, Inc.
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 QIAGEN N.V.
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Agilent Technologies, Inc.
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Abbott Laboratories
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Danaher Corporation
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 bioMérieux SA
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 PerkinElmer, Inc.
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Fluidigm Corporation
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 Eppendorf AG
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Promega Corporation
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 Analytik Jena AG (Endress+Hauser Group)
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Illumina, Inc.
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 Becton, Dickinson and Company (BD)
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Australia and New Zealand PCR Systems Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us